Imaging helps predict head and neck cancer survival

04/4/2013 | AuntMinnie.com (free registration)

A study published in the Journal of Nuclear Medicine found that in patients with head and neck cancer undergoing initial radiotherapy or chemoradiotherapy, a drop of at least 45% in the maximum standardized uptake value on FLT-PET/CT scans and a decrease of at least 31% in gross tumor volume measured using visual delineation were linked with a three-year disease-free survival rate of 88%. Three-year disease-free survival was 63% for other patients. Scans undertaken in the second week of therapy were the most useful in customizing treatment, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD